MeSH tree: D27.505.696.422.125
New research presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that, following treatment for obesity or diabetes or both, using incretin-based drugs, losing more weight versus less ...
May 9, 2026
0
7
A study has found that an emerging class of GLP-1 weight-loss drugs suppresses eating for pleasure, or hedonic feeding, in mice by modulating a reward circuit deep within the brain. This newly charted pathway—separate from ...
May 6, 2026
0
11
Metabolic and bariatric surgery offers significantly greater long-term protection against heart attack, stroke and death than widely used GLP-1 drugs in older adults with obesity and diabetes, according to a new real-world ...
May 6, 2026
0
6
A new real-world analysis of more than 90,000 patients with obesity and type 2 diabetes finds metabolic and bariatric surgery costs significantly less than weekly injections of GLP-1 drugs over a two-year period, according ...
May 5, 2026
0
5
Medications are available and delivered in various forms, including liquids, pills, injections, IV drips, inhalants, and suppositories, to name a few. But what makes one option, otherwise known as a delivery system, better ...
May 5, 2026
0
4
Drawing on electronic health records from nearly 20 million patients with severe obesity, researchers from University of California San Diego find that GLP-1 prescriptions have grown exponentially—from less than 4,600 prescriptions ...
May 5, 2026
0
4
The number of metabolic and bariatric surgery procedures in the United States dropped below 200,000 in 2024 for the first time since 2020, a more than 20% decline from the prior year, according to new research presented at ...
May 5, 2026
0
24
Glucagonlike peptide-1 (GLP-1) medications have taken over the national conversation around weight loss. From celebrity headlines to everyday conversations, GLP-1 drugs like Ozempic and Wegovy are often framed as breakthroughs ...
May 4, 2026
0
76
Inconsistent use of some GLP-1 weight-loss medications, like Ozempic and Wegovy, may significantly lessen their effectiveness, according to a new preclinical study from researchers at the Perelman School of Medicine at the ...
May 3, 2026
0
9
A new study from the University of St Andrews suggests weight-loss drugs like Ozempic taken around pregnancy do not raise the risk of major birth defects. Published in the American Journal of Obstetrics and Gynaecology, the ...
May 2, 2026
0
18
